XML 8 R2.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net sales $ 119,313 $ 118,307 $ 364,426 $ 381,659
Cost of sales (85,099) (101,014) (259,474) (284,185)
Gross profit 34,214 17,293 104,952 97,474
Operating expenses        
Selling, general and administrative (26,747) (26,365) (81,998) (86,885)
Research, product development and regulatory (5,654) (11,177) (17,139) (25,482)
Product liability claims (7,029) 0 (7,029) 0
Transformation (1,442) (8,139) (5,254) (16,636)
Asset impairment (93) 0 (227) 0
Gain from sale of asset 246 0 246 0
Operating loss (6,505) (28,388) (6,449) (31,529)
Change in fair value of equity investments (511) 0 (511) 513
Interest expense, net (4,920) (4,378) (13,135) (11,988)
Loss before provision for income taxes (11,936) (32,766) (20,095) (43,004)
Income tax (expense) benefit (422) 7,024 (1,574) 7,093
Net loss $ (12,358) $ (25,742) $ (21,669) $ (35,911)
Net loss per common share-basic $ (0.43) $ (0.91) $ (0.76) $ (1.28)
Net loss per common share-assuming dilution $ (0.43) $ (0.91) $ (0.76) $ (1.28)
Weighted average shares outstanding-basic 28,511 28,173 28,377 28,015
Weighted average shares outstanding-assuming dilution 28,511 28,173 28,377 28,015